Clinical Trials Browser

Ototoxicity, Neoplasms, Hearing Loss

NCT06551857 2025-04-16

CaSPiN

Recruiting

250 enrolled

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

NCT06929468 2025-04-16

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Not yet recruiting

55 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss

NCT05641441 2025-01-13

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

Recruiting

258 enrolled

CNS

Ototoxicity, Neuroma, Acoustic, Hearing Loss

NCT06490029 2024-07-08

BIO-OTOTOX

Recruiting

540 enrolled

Ototoxicity

NCT05946577 2023-07-14

AURACCO

Not yet recruiting

140 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Head and Neck Neoplasms, Salivary Gland Neoplasms, Tinnitus, Hearing Loss

NCT02890030 2020-04-08

The Platinum Study Comparison Group

Completed

102 enrolled

Genitourinary

Ototoxicity, Testicular Neoplasms, Neurotoxicity Syndromes

NCT00458887 2017-03-13

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Completed

301 enrolled

Ototoxicity

NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

Active not recruiting

50 enrolled

CNS

Ototoxicity, Central Nervous System Neoplasms

Clinical Trials

OTOPLAT

CaSPiN

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

BIO-OTOTOX

AURACCO

The Platinum Study Comparison Group

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy